Celecoxib/amlodipine besylate: Completed Phase III enrollment

Kitov completed enrollment of 150 patients in a double-blind, international Phase III trial comparing oral 200 mg celecoxib/10 mg amlodipine besylate once daily for 2 weeks vs. each of its components ...